Quantcast

World Stem Cell Markets Analyzed in New Report Published at MarketPublishers.com

January 11, 2012

With the potential of replacing defective or damaged cells resulting from disorders and injuries, stem cells are of great interest, leading to a variety of new regenerative therapies. New research report “Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development” prepared by Kalorama Information has been recently published by Market Publishers Ltd.

London, UK (PRWEB) January 11, 2012

With the potential of replacing defective or damaged cells resulting from disorders and injuries, stem cells are of great interest, leading to a variety of new regenerative therapies. Also, in vitro study of stem cells would offer the possibility for scientists to learn more about the function of various organs and the course of particular diseases, with stem cells to ultimately permit drug developers to test emerging therapies on diseased cells.

New research report “Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development” prepared by Kalorama Information has been recently published by Market Publishers Ltd.

Report Details:

Title: Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development

Published: January, 2012

Pages: 160

Price: US$ 3,995

http://marketpublishers.com/report/medicine_pharmaceuticals_biotechnology/drugs_biotechnology/stem_cells_worldwide_markets_4_transplantation_cord_blood_banking_n_drug_development.html

The research report provides the best, moderate and worst case scenarios for the three key markets for stem cells: stem cells in drug development, stem cells in cord blood banking, stem cell therapeutics. Stem cell therapeutics potentials are also provided broken down by disease.

Trends discussed in the report are as follows:

  •     ethical questions;
  •     U.S. — state and federal initiatives;
  •     research funding
  •     cord blood initiatives;
  •     international initiatives;
  •     stem cell patents;
  •     other healthcare regulations.

Report Contents:

Chapter One: Executive Summary

Scope and Methodolgy

Introduction

Current Stem Cell Therapies

Developmental Stem Cell Therapies

Issues In Stem Cell Research

Stem Cell Forecasts

Chapter Two: Introduction

The Promise of Stem Cells In Medical Treatment

Types of Stem Cells

Embryonic Stem Cells

Adult Stem Cells

Cord Blood Stem Cells

Stem Cell Harvesting

Embryonic Stem Cells

Therapeutic Cloning

Unfertilized Eggs

Adult Stem Cells

Leukapheresis

Peripheral Blood

Cord Blood Stem Cells

Transplantation Approaches

Autologous Transplantation

Allogenic Transplantation

Transplantation Procedures

Cancerous Stem Cells

Other Harmful Stem Cells

Stem Cells in Drug Development

Stem Cell Therapeutics

Stem Cells Targeting Drugs

Stem Cell Generated Organs

Chapter Three: Current Stem Cell Therapies

Cancer

Leukemia

Gene Therapy

Multiple Myeloma

Non-Hodgkin´s Lymphoma

Non Cancerous Diseases

Aplastic anemia

Immunodeficiency

Lupus

Sickle Cell Disease

Other Conditions

Chapter Four: Developmental Stem Cell Therapies

Alzheimer´s Disease

Arthritis

Bladder Disease

Burns

Cancer

Cardiovascular Conditions

More new research reports by the publisher can be found at Kalorama Information page.

###

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/1/prweb9096738.htm


Source: prweb



comments powered by Disqus